Barrier tissue dysfunction is a fundamental feature of chronic human inflammatory diseases 1 . Specialized subsets of epithelial cells-including secretory and ciliated cells-differentiate from basal stem cells to collectively protect the upper airway 2-4 . Allergic inflammation can develop from persistent activation 5 of type 2 immunity 6 in the upper airway, resulting in chronic rhinosinusitis, which ranges in severity from rhinitis to severe nasal polyps 7 . Basal cell hyperplasia is a hallmark of severe disease 7-9 , but it is not known how these progenitor cells 2,10,11 contribute to clinical presentation and barrier tissue dysfunction in humans. Here we profile primary human surgical chronic rhinosinusitis samples (18,036 cells, n = 12) that span the disease spectrum using Seq-Well for massively parallel single-cell RNA sequencing 12 , report transcriptomes for human respiratory epithelial, immune and stromal cell types and subsets from a type 2 inflammatory disease, and map key mediators. By comparison with nasal scrapings (18,704 cells, n = 9), we define signatures of core, healthy, inflamed and polyp secretory cells. We reveal marked differences between the epithelial compartments of the non-polyp and polyp cellular ecosystems, identifying and validating a global reduction in cellular diversity of polyps characterized by basal cell hyperplasia, concomitant decreases in glandular cells, and phenotypic shifts in secretory cell antimicrobial expression. We detect an aberrant basal progenitor differentiation trajectory in polyps, and propose cell-intrinsic 13 , epigenetic 14,15 and extrinsic factors 11,16,17 that lock polyp basal cells into this uncommitted state. Finally, we functionally demonstrate that ex vivo cultured basal cells retain intrinsic memory of IL-4/IL-13 exposure, and test the potential for clinical blockade of the IL-4 receptor α-subunit to modify basal and secretory cell states in vivo. Overall, we find that reduced epithelial diversity stemming from functional shifts in basal cells is a key characteristic of type 2 immune-mediated barrier tissue dysfunction. Our results demonstrate that epithelial stem cells may contribute to the persistence of human disease by serving as repositories for allergic memories.
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Supplementary Discussion V). Additionally, substantial numbers of mast cells expressed IL5 and IL13, and, along with myeloid cells, were the main expressers of the tissue-reparative cytokine AREG 22 . Notably, patients with or without polyps showed consistent cells-of-origin for T2I-related chemokines, lipids and cytokines, with the exception of select mediators (Extended Data Fig. 4a, b ; Supplementary Discussion IV). Expression of several genes implicated in allergic diseases 24 by genome-wide association studies (GWAS) was restricted to specific cell types. We therefore mapped the expression of candidate risk genes, including GATA2, IL1RL1 (which encodes the IL-33 receptor ST2 subunit), CDHR3, KIF3A, TMEM232 and MYC (Extended Data Fig. 4f ; Supplementary Discussion VI). Cellular maps of tissues commonly affected by inflammatory disease should help to provide mechanistic insights into genotype-phenotype interactions.
We further analysed the epithelial clusters ( Fig. 2a , Extended Data Fig. 5a-c) , providing single-cell human transcriptomes 25 for basal, secretory, glandular and ciliated cell types from a T2I ecosystem ( Fig. 2a, b , Extended Data Fig. 5 , Supplementary Table 3 ). Analysis of epithelial marker genes identified conserved transcriptional programs in basal (three clusters), differentiating/secretory (three clusters), glandular (two clusters) and ciliated (one cluster) cell types 2, 3 (Fig. 2a, b , Extended Data Fig. 5a -d, Supplementary Table 3 ; Supplementary Discussion VII).
On the basis of our observation of striking polyposis-related differences across clusters within cell types (Fig. 2c , Extended Data Fig. 5e ; Supplementary Discussion VIII), we quantified the numerical over-representation of cells from the non-polyp and polyp ecosystems within each cluster and type. The clusters comprising basal, differentiating/secretory, and glandular cells showed the most significant links to the disease state (P values by Fisher's least-significant difference test; Fig. 2c , Supplementary Table 3 ). We compared transcriptomes of differentiating/secretory cells 3 (containing KRT8-expressing secretory and apical goblet cells), noting that secretory cells from polyps appear to supplant antimicrobial function with tissue repair (Fig. 2d , Supplementary Table 3 ; Supplementary Discussion VIII).
Of note, we observed expression of MUC5B within glandular mucus cells (cluster 13), whereas MUC5AC was expressed in a distinct subset of secretory goblet cells co-expressing SCGB1A1 and FOXA3 (Fig. 2b , Extended Data Fig. 5f , g; Supplementary Discussion IX). This suggests that the goblet cell program is overlaid on a secretory cell base 2 . We also assessed glandular heterogeneity, identifying five discrete subsets with variegated antimicrobial expression 3 (Fig. 2a, Extended Data Fig. 6a , b, Supplementary Table 3 ; Supplementary Discussion IX). This compartmentalization may represent a mechanism for regulated secretion, with imbalances in cell types or states affecting innate host defence.
To contextualize shifts associated with disease state, we turned to sinonasal scrapings as a method of sampling healthy apical cells through Seq-Well (Extended Data Fig. 6c, d , Supplementary Tables 3, 6 ; 18,704 additional cells: n = 3 healthy inferior turbinate (InfTurb), n = 4 polyp-patient InfTurb, n = 2 EthSin-polyp directly). We recovered immune cells and differentiating/secretory and ciliated epithelial cells from the InfTurb of patients with polyposis and healthy controls, but basal cells were found only in polyp scrapings (Extended Data Fig. 6d -f, Supplementary Table 3 ; Supplementary Discussion X). By combining all epithelial cells from the surgical resections with scrapings ( Fig. 2a-c, e ), we identified a conserved core secretory gene set that was present in all sites sampled, as well as healthy, CRS-InfTurb, CRS-EthSinnon-polyp and CRS-EthSin-polyp specific gene signatures. Overall, we note a shift from IFN-α/IFN-γ-induced genes to IL-4/IL-13-induced genes with increasing disease severity ( Fig. 2e -g, Supplementary Table 3 ; Supplementary Discussion XI). Secretory cells from involved CRS-EthSin tissue differ markedly from those of the InfTurb, and secretory cells in non-polyp and polyp EthSin reach distinct states in which altered functionality may be linked to severity of disease.
As specialized epithelial cell types arise from basal progenitors 2,10 , we formally examined their distribution in each sample ( Fig. 3a , Extended Data Fig. 7a ). Our data indicate a significant loss of epithelial ecological diversity in nasal polyps by Simpson's index (see Methods), largely driven by glandular and ciliated cell depletion, and an enrichment in basal cells ( Fig. 3a, b , Extended Data Fig. 7a-d ; Supplementary Discussion XII). This altered diversity tracked closely with rankordered pathology of patient tissue samples, which correlated positively with basal cell frequency (r = 0.6252) and negatively with epithelial diversity (r = −0.6824; Extended Data Fig. 7e ). We hypothesize that alterations in the immune compartment in polyps may represent an overcorrection in attempting to balance epithelial shifts (Extended Data Fig. 7f ; Supplementary Discussion XII).
To confirm our findings on epithelial cell types, we applied complementary approaches. Using flow cytometry 10 , we demonstrated that the frequency of basal cells significantly increased in polyps at the expense of differentiated epithelial cells in 13 additional patients ( Fig. 3c , Extended Data Fig. 7g , h). Using histology (which, unlike scRNA-seq or flow cytometry, is not subject to dissociationinduced artefacts), we confirmed 8 a significant increase of p63 + cells per 1,000 μm 2 of epithelial area and a striking loss of glands in polyps ( Fig. 3d , e, Extended Data Fig. 7i , j). We also used marker genes for specialized lineages to deconvolve bulk EthSin-tissue RNA sequencing (RNA-seq) from an additional cohort of 27 individuals. We identified four patient clusters and confirmed glandular enrichment in non-polyps, and shifts in secretory cell states and the progressive acquisition of basal-associated transcripts in polyps ( Fig. 2d, f, 3f , g, h, Supplementary  Tables 1, 3 ; Supplementary Discussion XIII). Finally, we validated these findings with publicly-available RNA-seq datasets containing normal human sinus tissue and polyps (Extended Data Fig. 7k , l; Supplementary Discussion XIII).
To investigate mechanisms that might account for the reduced epithelial diversity in polyps, we compared the transcriptomes of Basal (12, 8, 2) Apical (1, 0, 4) Glandular (13, 3) Ciliated (16) Fibroblast (5, 14) Endothelial (6) Plasma cell (7, 10, 15, 17) T cell (9) Myeloid (11) Mast cell (18) non-polyp and polyp basal progenitors 2,10 , identifying increased expression of transcripts involved in extracellular matrix remodelling and chemo-attraction of effector cells, and a decrease in protease-inhibitor expression and metabolic genes in polyps ( Fig. 4a ). As some of these upregulated genes are canonical IL-4/IL-13 responsive transcripts 7 , we assessed cytokine-induced gene sets. A combined IL-4/IL-13 signature is strongly induced not only in differentiated polyp epithelium, but also in basal cells, with a large effect size between disease states ( Fig. 4b , c, Extended Data Fig. 8a , Supplementary Table 4 ). IFN-α and IFN-γ signatures-indicative of a type 1 immune module 6 -had small effect sizes (Extended Data Fig. 8b , Supplementary Table 4 ). Furthermore, from specific hallmark genes, we observed altered balance between Wnt (CD44) and Notch (HEY1) signalling in polyp epithelium favouring Wnt 26, 27 (Fig. 4a , c, Supplementary Table 4 ). We further contextualized our basal cell findings by defining alterations in the fibroblast niche that correlate with basal hyperplasia, and identifying significant changes in myeloid and endothelial cell gene expression (Extended Data Figs. 7b, 8c-f; Supplementary Discussion XIV, XV).
Next, we used diffusion pseudotime mapping (see Methods), aligning and reconstructing how basal cells differentiate to mature secretory cells to identify where basal cells become 'stuck' in polyps. In the nonpolyp ecosystem, we observed that basal cells traverse a wider swath of common pseudotime, with the majority of secretory cells distributed towards the trajectory's terminus ( Fig. 4d , e, Extended Data Fig. 9a ). Conversely, in polyps, basal cells accumulate shy of the trajectory's midpoint, losing the true progenitor position occupied by cluster 8, yet failing to contribute towards later differentiation states ( Fig. 4d , e, Extended Data Fig. 9a ). Ordering cells along this common axis, we identified several genes that were dysregulated in polyps during epithelial cell differentiation (Extended Data Fig. 9b , Supplementary Table 3 ; Supplementary Discussion XVI).
As these data highlighted an impairment in differentiation of basal cells in polyp tissue, we sorted basal cells (Extended Data Fig. 7h ) from three non-polyp and seven polyp tissues and performed Omni assay for transposase-accessible chromatin (ATAC) sequencing (Omni-ATACseq) to identify intrinsic epigenetic changes from the integration of extrinsic cellular signalling events 28 , and subsequent bulk RNA-seq to confirm and extend our findings (Methods). Polyp basal cells were enriched in peaks for bZIP transcription factor motifs, including various AP-1 family members 11 such as JUN, along with FOXA1, ATF3, KLF5 and p63, which have been associated with the maintenance of an undifferentiated state, chromatin opening and oncogenesis ( Fig. 4f Collectively, our transcriptomic, pseudotemporal and epigenetic studies led us to hypothesize that during chronic T2I, basal cell differentiation is intrinsically impaired through the influence of extrinsic cues (notably, activation of IL-4/IL-13 and Wnt pathways).
To functionally test for intrinsically altered differentiation potential in vitro, we first seeded basal cells from non-polyp or polyp tissue into air-liquid interface (ALI) cultures ( Fig. 5a , Extended Data Fig. 9g , Supplementary Table 3 ; Supplementary Discussion XIX). Our results suggest that basal cells from polyps can be released from their 'stuck' state and differentiate towards a mixed-tissue secretory cell phenotype CD9  POSTN  IGFBP3  EGLN3  PTHLH  CST2  CST4  SERPINB3  ALOX15  TFF3  CST1   RPS8  BPIFB1  COX7C  SNHG8  RARRES1  MGST1  S100A13  HES1  BTG2  UGT2A2  EGR1  CXCL17  JUNB  IER3  ZFP36  DUSP1  SCGB1A1  RPL30  RPS12  TPT1  SLPI   S100P  S100A4  ALDH3A1  KRT7  MUC1  CEACAM5  CEACAM6  LCN2  RNA28S5  ANKRD36C  MUC4  S100A8  S100A9  C15orf48  SAT1  HLA−B   TMSB4X  PIGR  S100A6  AGR2  TSPAN1  VMO1 LGALS3 WFDC2 Letter reSeArCH if provided with strong and sustained extrinsic cues, even in the presence of IL-13 ( Fig. 5b ; Extended Data Figs. 7h, 9f, h, i; Supplementary Discussion XIX).
Second, since ALI cultures enforced strong terminal differentiation, we directly tested how IL-4/IL-13 act to induce rapid expression of genes in basal cells cultured for 5 weeks ex vivo, hypothesizing that polyp basal cells would respond more vigorously to exogenous cytokines than non-polyp basal cells 14 . Surprisingly, we identified 482 genes that were induced in non-polyp basal cells, but only 42 in polyps ( Fig. 5c , Supplementary Table 3 ). Principal component analysis (PCA) highlighted that whereas unstimulated non-polyp basal cells grouped together, polyp basal cells were distributed along PC1, which captured cytokine stimulation ( Fig. 5c ). Identifying overlaps in genes that are significantly induced by cytokine treatment in non-polyp basal cells with genes that are upregulated at baseline in polyp versus non-polyp basal cells resolved 132 genes ( Fig. 5c , Supplementary Table 3 ).
We focused on the central overlap of these three differential expression tests, which included CTNNB1 (β-catenin), the key effector of Wnt pathway activation 26, 27 (Fig. 5c ). We highlight the fundamental finding that CTNNB1 was robustly induced in non-polyp and polyp basal cells in a dose-sensitive fashion to IL-4 and IL-13. Moreover, baseline CTNNB1 expression in polyp basal cells was equivalent to the levels induced by cytokine treatment of non-polyp cells (Fig. 5d ). Wntpathway target genes were significantly upregulated across the tested doses, confirming overall activation of the pathway, and of specific factors (such as CTGF) ( Fig. 5d , Extended Data Fig. 9j , Supplementary  Table 4 ; Supplementary Discussion XX). On the basis of polyp epithelial gene signatures ( Fig. 4c ) and our functional testing for IL-4/ IL-13 induced genes 'remembered' by polyp basal cells ( Fig. 5c, d ), we propose that chronic IL-4/IL-13 exposure in vivo can lead to persistent expression of Wnt/β-catenin target genes in a cell-intrinsic fashion, even in the absence of exogenous cytokines.
One polyp patient sampled through scraping commenced treatment with a monoclonal antibody targeting the shared IL-4Rα subunit of the IL-4 and IL-13 receptors to treat atopic dermatitis, which provided an opportunity to examine the in vivo relevance of our observational, mechanistic and functional data on how T2I cytokines influence basal cell states ( Fig. 5e , Extended Data Fig. 10a, b ). We compared cells recovered from pre-and 6-week-post-antibody treatment scrapings, and through surgical intervention at 7 weeks after antibody treatment ( Fig. 5e , Extended Data Fig. 10a , b, Supplementary  Table 7 ; Supplementary Discussion XXI). We identified basal cells and LGR6
Basal cells Omni-ATAC-seq enriched motifs Table 3 ). b, Violin plot (Extended Data Fig. 8 ; cell numbers in Supplementary Table 3 , genes listed in Supplementary Table 4 Table 3 generated a heat map containing their top marker genes, agnostic to treatment, followed by genes that were differentially expressed preand post-treatment, leveraging myeloid cells to identify basal-specific changes ( Fig. 5f , Extended Data Fig. 10a -c, Supplementary Table 3 ; Supplementary Discussion XXI).
In the context of our earlier findings, these results enabled us to identify several key gene sets, including a conserved core set of basal cell genes (Extended Data Fig. 10d ). Several transcription factors that are upregulated in polyp basal cells identified through Omni-ATACseq and RNA-seq (ATF3, KLF5 and FOSB) were significantly downregulated after treatment ( Fig. 5g ). Whereas Wnt pathway target gene expression was globally reduced, CTNNB1 expression was retained, as was expression of genes that are upregulated both in vitro and in vivo in polyp basal cells, suggesting that some disease-associated genes in this patient, and at this time point, persist ( Fig. 5g , Extended Data Fig. 10d ; Supplementary Discussion XXI).
Lastly, we sought to understand how changes in the basal epithelium propagated through to secretory cells. Within secretory cells recovered from scrapings of both InfTurb and accessible polyp tissue pre-and post-treatment, our data suggest that even though CRS-EthSin samples have unique secretory cell signatures ( Fig. 2f ), cytokine blockade leads to expression of genes associated with healthy InfTurb secretory cells, even in polyp tissue (Extended Data Fig. 10e -h, Supplementary Table 8 ; Supplementary Discussion XXI).
One goal of understanding the cellular and molecular pathways activated in T2I is to provide mechanisms that explain persistent chronic allergic inflammatory disease 29 . Using scRNA-seq applied to patients across the CRS spectrum, our study provides descriptive, mechanistic and functional insights into an enigmatic basal cell state and productive differentiation of a barrier tissue. We reveal differences in expression of antimicrobial genes by secretory cells relative to healthy tissue, a loss of glandular cell heterogeneity, and strong induction of a transcriptional program by IL-4/IL-13 at the level of basal progenitor cells 15 . Our data may help to explain why nasal polyposis is associated with infections by specific microorganisms 7 , and how a monoclonal antibody that targets the shared IL-4/IL-13 receptor can reduce nasal polyp burden.
Together with recent work in the murine intestinal tract and skin 11, 13, 16, 17, 30 , our results provide evidence in humans for the emerging paradigm of stem cell dysfunction altering the set point of barrier tissues, highlighting substantial overlap among putative driving transcription factors (ATF3, AP-1, p63 and KLF5) 13 . This demonstrates that the principle of inflammatory memory 28 underlying barrier tissue adaptation is a generalizable phenomenon that is observed in distinct anatomical locations, inflammatory modules, and species. We build on these findings by culturing basal cells ex vivo and identifying the indelible mark of IL-4/IL-13 as a baseline induction of the Wnt pathway. We propose that basal cells form 'memories' of chronic exposure to an inflammatory T2I environment, shifting the entire cellular ecosystem away from productive differentiation and propagating disease. Future work will seek to determine the relative contributions of memory stored in distinct cellular compartments to develop the most effective mechanisms by which to erase them.
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In vivo basal cells Table 1 ). The Institutional Review Board approved the study, and all subjects provided written informed consent. Ethmoid sinus (EthSin) tissue was collected at the time of elective endoscopic sinus surgery from patients with physician-diagnosed CRS with and without nasal polyps on the basis of established guidelines 31 . Patients with polyps included patients with aspirin-tolerant chronic rhinosinusitis with nasal polyps (CRS polyp) and individuals with aspirin-exacerbated respiratory disease (AERD), both of which are referred to as CRS-EthSin-polyp for the purposes of this study. Patients were suspected of having AERD if they had asthma, nasal polyposis, and a history of respiratory reaction on ingestion of a COX 1 inhibitor, with confirmation via a graded oral challenge to aspirin. Subjects with cystic fibrosis and unilateral polyps were excluded from the study. No distinctions were made between these two disease endotypes in our study, as both present with polyposis, but we present the clinical diagnoses in Supplementary Table 1 .
A tissue segment (one per patient) for bulk tissue RNA-seq was immediately placed in RNAlater (Qiagen) for RNA extraction, For patient samples loaded on Seq-Well and for flow-sorting to Omni-ATAC-seq/RNA-seq, tissue was received in-hand, placed in RPMI (Corning) with 10% FBS (ThermoFisher 10082-147) and immediately put on ice for transport. Details of the subjects' characteristics included in scRNA-seq cohort, tissue RNA-seq cohort, and basal cell flow cytometry/ ATAC-seq/RNA-seq cohort (including age, gender, medication use, and disease severity) are included in Supplementary Table 1 .
Originally, we enrolled a healthy control subject with no known history of CRS or nasal polyposis who was undergoing sinus surgery for concha bullosa. However, this subject upon pathology evaluation was found to have mild eosinophilia. A chart review revealed a history of allergic rhinitis and asthma, and their diagnosis was updated to CRS non-polyp clinically by the surgeon upon follow-up visits so we updated their status accordingly in our study. Additionally, non-polyp patient 6 was sampled twice (denoted as 6A and 6B), representing distinct cells that were captured on two different Seq-Well arrays. As such, they should not be viewed as a technical replicate and are referred to as distinct samples.
Collection of inferior turbinate and nasal polyp samples through nasal scraping.
Nasal samples were collected from the inferior turbinate (InfTurb) of healthy control subjects and from the inferior turbinate and accessible polyp tissue in subjects with CRS-EthSin-polyps using the Rhino-Pro Curette, a sterile, disposable, mucosal collection device, as described 32, 33 . One sample was taken from the right and left mid-inferior portion of the inferior turbinate using a gentle scraping motion. In two subjects with CRS polyp, with accessible nasal polyp tissue, the polyp tissue was sampled using the Rhino-Pro Curette under direct visualization. The nasal scrapings were placed directly in RPMI with 10% FBS and immediately put on ice for transport before loading on Seq-Well arrays. Details of the subjects' characteristics (including age, gender, medication use and disease severity) are included in Supplementary Table 1 .
Nasal scraping allows for access to the superficial epithelial cell layer of the inferior turbinate 34 ; by contrast, the surgical resections from EthSin that we utilize as the central dataset of this paper contain both epithelial cells and underlying tissue, including sub-mucosal glands 34 (Extended Data Fig. 6c ). Since scraping samples a proximal but distinct anatomical location with a distinct technique, in addition to collecting InfTurb scrapings from healthy controls (n = 3), we also collected InfTurb scrapings from individuals with polyps (n = 4), and, from two of these individuals, from accessible polyps protruding beyond the middle meatus (n = 2).
One subject with CRS polyps and co-morbid severe atopic dermatitis was started on dupilumab 35 , a human monoclonal antibody that binds to the IL-4Rα subunit, which is approved for severe atopic dermatitis 36 , and in a randomized, double-blind, placebo-controlled parallel-group study was shown to significantly reduce endoscopic nasal polyp burden after 16 weeks 37 . The inferior turbinate and nasal polyp tissue was sampled with the Rhino-Pro Curette pre-and post-treatment with 3 doses of dupilumab, and through endoscopic sinus surgery as noted above. Tissue digestion. Single-cell suspensions from collected surgical specimens were obtained using a modified version of a previously published protocol 38 , described below in detail. Each specimen was received directly in hand and processed directly with an average time from patient to loading onto the Seq-Well platform of 3 total hours, and never exceeding 4 h. Surgical specimens were collected into 30 ml of ice cold RPMI (Corning). Specimens were finely minced between two scalpel blades and incubated for 15 min at 37 °C in a rotisserie rack with end-over-end rotation in 25 ml digestion buffer supplemented with 600 U/ml collagenase IV (Worthington) and 20 μg/ml DNase 1 (Roche) in RPMI with 10% fetal bovine serum. After 15 min, samples were triturated five times using a syringe with a 16G needle and returned to the rotisserie rack for another 15 min. At the conclusion of the second digest period, samples were triturated an additional five times using a syringe with a 16G needle, at which point the digest process was stopped via the addition of EDTA to 20mM. Nasal scrapings were dissociated with one 15 min dissociation using collagenase and the 16G needle trituration was omitted and instead replaced with P1000 pipette trituration, as cell yields were typically <20,000 total cells. Processing downstream remained identical. Samples were typically fully dissociated at this step and were filtered through a 70-μm cell strainer and spun down at 500g for 10 min followed by a rinse with ice-cold PBS (ThermoFisher 10010023, Ca/Mg-free) to 30 ml total volume. Red blood cells (RBCs) were lysed using ACK buffer (ThermoFisher A1049201) for 3 min on ice to remove RBCs, even if no RBC contamination was visibly seen in order to maintain consistency across patient groups. Cells were then washed with sterile PBS and spun down at 500g for 5 min, resuspended in complete RPMI medium with 2% FCS (RPMI1640 (ThermoFisher 61870-127), 100 U/ml penicillin (ThermoFisher 15140-122), 100 μg/ml streptomycin (ThermoFisher 15140-122), 10 mM HEPES (ThermoFisher 15630-080), 2% FCS (ThermoFisher 10082-147), 50 μg/ml gentamicin (ThermoFisher 15750-060)), and counted to adjust concentration to 100,000 cells per ml for loading onto Seq-Well arrays. Flow cytometry, cell sorting, and analysis. Single-cell suspensions in FACS Buffer (HBSS (ThermoFisher 14170161, Ca/Mg-free) supplemented with 2% FCS) were pre-incubated with Fc-Block (BD 564220) before staining for surface antigens. The following antibodies were used to identify basal cells via flow cytometry: FITC anti-human THY1 (Biolegend, clone 5E10), Brilliant Violet 421 antihuman CD45 (Biolegend, clone HI30), Brilliant Violet 650 anti-human EPCAM (Biolegend, clone 9C4), APC/Cy7 anti-human ITGA6 (Biolegend, clone GoH3), PE/Cy7 anti-human NGFR (Biolegend, clone ME20.4), APC anti-human PDPN (Biolegend, clone NC-08). Cells were stained for 30 min on ice in FACS buffer and then washed for immediate sorting. Cells were sorted on a BD FACSAria Fusion cell sorter using BD FACSDiva software. Up to 10,000 basal cells were sorted into 100 μl BAM banker (Wako chemicals) for Omni-ATAC-seq and cooled to −80 °C using a Mr. Frosty freezing container (Thermo scientific). Samples were stored at −80 °C until thawed for Omni-ATAC-seq. For bulk RNA-seq, 1,000 basal cells were sorted directly into 5 μl TCL buffer (Qiagen). FlowJo v10 by TreeStar was used to generate plots. Histologic analyses. Biopsies were fixed in 4% paraformaldehyde, embedded in paraffin, and 6-μm sections were prepared and stained with haematoxylin and eosin for quantification of glandular areas. Photomicrographs encompassing the entire area of each biopsy were taken. Total and glandular areas were measured with ImageJ software and expressed as glandular area as a percentage of total area. For p63 immunofluoresence, sections were quenched for 10 min in 1 mg/ml sodium borohydride in PBS. For antigen retrieval, slides were placed in a Coplin jar with preheated citrate target retrieval buffer (DAKO) at 95 °C and transferred to a steamer for 60 min. Slides were cooled for 20 min at room temperature and then transferred to distilled water followed by PBS. Samples were blocked with serum free protein block (DAKO) containing 5% normal donkey serum for 60 min. Samples were incubated overnight at 4 °C with purified anti-TP63 antibody (Biolegend, clone W15093A). After three washes in PBS-T, samples were incubated with 1:500 Alexa Fluor 647-conjugated donkey anti-mouse IgG (Jackson immunoresearch, catalogue# 715-605-150) and 1:10,000 Hoescht nuclear dye. Quantification of p63 + cells was performed in a blinded fashion and involved counting of p63 + nuclei relative to background staining with an isotype control primary antibody. As the epithelium can vary in length across sections, we normalized our quantification of total positive nuclei per 1,000 μm 2 area of epithelium as measured in ImageJ and report the final value as p63 + cells per 1,000 μm 2 of epithelium. Single-cell RNA-seq with Seq-Well. Once a single-cell suspension was obtained from freshly resected EthSin tissue, or scrapings from InfTurb, we used the Seq-Well platform for massively parallel scRNA-seq to capture transcriptomes of single cells on barcoded mRNA capture beads. Full methods on implementation of this platform are available 12 . In brief, 20,000 cells were loaded onto one array preloaded with barcoded mRNA capture beads (ChemGenes). The loaded arrays containing cells and beads were then sealed using a polycarbonate membrane with a pore size of 0.01 μm, which allows for exchange of buffers but retains biological molecules confined within each nanowell. Subsequent exchange of buffers allows for cell lysis, transcript hybridization, and bead recovery before performing reverse transcription en masse. Following reverse transcription using Maxima H Minus Reverse Transcriptase (ThermoFisher EP0753) and an Exonuclease I treatment (NewEngland Biolabs M0293L) to remove excess primers, PCR amplification was carried out using KAPA HiFi PCR Mastermix (Kapa Biosystems KK2602) with 2,000 beads per 50 μl reaction volume. Libraries were then pooled in sets of six (totaling 12,000 beads) and purified using Agencourt AMPure XP beads (Beckman Coulter, A63881) by a 0.6X SPRI followed by a 0.7X SPRI and quantified using Qubit hsDNA Assay (Thermo Fisher Q32854). Quality of WTA product was assessed using the Agilent hsD5000 Screen Tape System (Agilent Genomics) with an expected peak >1,000 bp tailing off to beyond 5000 bp, and a small or Letter reSeArCH non-existent primer peak, indicating a successful preparation. Libraries were constructed using the Nextera XT DNA tagmentation method (Illumina FC-131-1096) on a total of 600 pg of pooled cDNA library from 12,000 recovered beads using index primers with format as in Gierahn et al. 12 . Tagmented and amplified sequences were purified at a 0.6X SPRI ratio yielding library sizes with an average distribution of 650-750 base pairs in length as determined using the Agilent hsD1000 Screen Tape System (Agilent Genomics). Two arrays were sequenced per sequencing run with an Illumina 75 Cycle NextSeq500/550v2 kit (Illumina FC-404-2005) at a final concentration of 2.2-2.8 pM. The read structure was paired end with read 1 starting from a custom read 1 primer 12 containing 20 bases with a 12-bp cell barcode and 8-bp unique molecular identifier (UMI) and read 2 containing 50 bases of transcript information. Single-cell RNA-seq computational pipelines and analysis. Read alignment was performed as in Macosko et al. 39 . In brief, for each NextSeq sequencing run, raw sequencing data was converted to demultiplexed FASTQ files using bcl2fastq2 based on Nextera N700 indices corresponding to individual samples/arrays. Reads were then aligned to Hg19 genome using the Galaxy portal maintained by the Broad Institute for Drop-Seq alignment using standard settings. Individual reads were tagged according to the 12-bp barcode sequenced and the 8-bp UMI contained in Read 1 of each fragment. Following alignment, reads were binned onto 12-bp cell barcodes and collapsed by their 8-bp UMI. Digital gene expression matrices (for example, cells-by-genes tables) for each sample were obtained from quality filtered and mapped reads, with an automatically determined threshold for cell count. UMI-collapsed data was used as input into Seurat 40 (https://github. com/satijalab/seurat) for further analysis. Before incorporating a sample into our merged dataset, we individually inspected the cells-by-genes matrix of each as a Seurat object.
For analysis of all sequenced surgical ethmoid sinus resection samples, we merged UMI matrices across all genes detected in any condition and generated a matrix retaining all cells with at least 500 UMI detected (19, 196 cells and 31,032 genes). This table was then used to set up the Seurat object in which any cell with at least 300 unique genes was retained and any gene expressed in at least 5 cells was retained (Supplementary Information; an R Script is included from this point to set up the Seurat object and walk reader through dimensionality reduction and basic data visualization). The object was initiated with lognormalization, from a UMI + 1 count matrix, scaling, and centering set to True. The total number of cells passing these filters captured across all patients was 18,624 cells with 22,575 genes, averaging 1,503 cells per sample with a range between 789 cells and 3,109 cells (Extended Data Fig. 1a, b , Supplementary Table 2 ). Before performing dimensionality reduction, data was subset to include cells with less than 12,000 UMI, and a list of 1,627 most variable genes was generated by including genes with an average normalized and scaled expression value greater than 0.13 and with a dispersion (variance/mean) greater than 0.28. We then performed principal component analysis (PCA) over the list of variable genes. For both clustering and t-stochastic neighbour embedding (t-SNE), we used the first 12 principal components, as upon visual inspection of genes contained within, each contributed to a non-redundant cell type and this reflected the inflection point of the elbow plot. We used FindClusters within Seurat (which utilizes a shared nearest neighbour (SNN) modularity optimization based clustering algorithm) with a resolution of 1.2 and t-SNE set to fast with the Barnes-Hut implementation to identify 21 clusters across the 12 input samples.
For analysis of all sequenced InfTurb scraping samples, the object was initiated with log-normalization, from a UMI + 1 count matrix, scaling, and centering set to true. The total number of cells passing these filters captured across all patients was 18,704 cells with 24,842 genes, averaging 2,078 cells per sample with a range between 65 cells and 5,625 cells (note: The 65-cell sample was a very mucus-laden polyp inferior turbinate sample, perhaps explaining the low cell yield, but clustered well within the three other samples each containing 253, 599, and 1,381 cells). Before performing dimensionality reduction, data was subset to include cells with less than 10,000 UMI, and a list of 1,499 most variable genes was generated by including genes with an average normalized and scaled expression value greater than 0.22 and with a dispersion (variance/mean) greater than 0.26. We then performed PCA over the list of variable genes. For both clustering and t-SNE, we used the first 16 principal components, as upon visual inspection of genes contained within, each contributed to a non-redundant cell type and this reflected the inflection point of the elbow plot. We used FindClusters (which utilizes an SNN modularity optimization based clustering algorithm) with a resolution of 1 and t-SNE set to fast with the Barnes-Hut implementation to identify 18 clusters across the 9 input samples.
For analysis of all sequenced ALI cultures, the object was initiated with lognormalization, from a UMI + 1 count matrix, scaling, and centering set to true. The total number of cells passing these filters captured across all patients was 16,173 cells with 27,396 genes, averaging 2,448 cells per sample with a range between 1,980 cells and 3,009 cells. Before performing dimensionality reduction, data was subset to include cells with less than 25,000 UMI, and a list of 1,670 most variable genes was generated by including genes with an average normalized and scaled expression value greater than 0.35 and with a dispersion (variance/mean) greater than 0.35. We then performed PCA over the list of variable genes. For both clustering and t-SNE, we used the first 16 principal components, as upon visual inspection of genes contained within, each contributed to a non-redundant cell state and this reflected the inflection point of the elbow plot. We used FindClusters (which utilizes an SNN modularity optimization based clustering algorithm) with a resolution of 0.6 and t-SNE set to fast with the Barnes-Hut implementation to identify 11 clusters across the 4 input samples. Cell type identification and within cell type analysis. To identify genes which defined each cluster, we performed a ROC test implemented in Seurat with a threshold set to an area under the curve of 0.65. Top marker genes with high specificity were used to classify cell clusters into cell types (Fig. 1a-c ; Extended Data Fig. 1e ) based on existing biological knowledge. Three clusters were considered doublets (588 cells) based on co-expression of markers indicative of distinct cell types at ~1/2 the expression level detected in the parent cell cluster (for example, T cell and myeloid cell) and removed from further analyses yielding a matrix with 18,036 cells used in all subsequent steps. Closely related clusters were merged to cell types based on biological curation and analysis of hierarchical cluster trees yielding ten total cell types ( Fig. 1a-c; Extended Data Fig. 1e ). We identified a much smaller number of eosinophils than expected in our single-cell data. Specifically, if we do not place bulk tissue immediately into RNA-later within 10 min, we cannot reliably detect eosinophil associated transcripts. However, flow cytometrically we recover from 0.5% to 5% of total cells fitting eosinophil profiles from polyps, and focused single-cell studies on granulocytes at the expense of the full ecosystem are possible and the topic of future work (data not shown). With the gentler tissue dissociation required for scrapings, we recovered a greater frequency of eosinophils from polyps in line with flow data (0.31% to 4.6% of cells; Extended Data Fig. 6d ). We also did not find a distinct cluster of ILCs, as they are around 0.01 to 0.1% of CD45 cells across the CRS spectrum, per existing literature 41 , and extrapolating to the number of CD45 cells we captured, we would have detected between 0.8 and 8 ILCs. To investigate further granularity present within cell types, such as T cells, myeloid cells, fibroblasts, endothelial cells, and epithelial cells, we subset these cells from the Seurat object and re-ran dimensionality reduction and clustering (Extended Data Figs. 3, 4 and 6) . The process used for clustering and subset identification was adapted for each cell type to optimize the parameters of variable genes, principal components, and resolution of clusters desired. Canonical correlation analysis 42 (CCA) was also performed to validate epithelial cell type classification across disease states (Extended Data Fig. 5; Supplementary Information) .
Differential expression and fractional contribution of gene set to transcriptome.
To identify differentially expressed genes within cell types across non-polyp and polyp disease states, we used the 'bimod' setting in FindMarkers implemented in Seurat based on a likelihood ratio test designed for single-cell differential expression incorporating both a discrete and continuous component 43 . To determine the expression contribution to a cell's transcriptome of a particular gene list, we summed the total log-normalized expression values for genes within a 'list of interest' and divided by the total amount of log-normalized transcripts detected in that cell, giving the proportion of a cell's transcriptome dedicated to producing those genes. For comparison of Wnt and Notch signalling, we z-scored the expression contribution metric and subtracted the value of Notch from Wnt yielding a metric centred on zero if both scores are equivalent, or weighted in the positive direction if enriched in Wnt. For reference gene lists used, including basal cell 44 ; genes induced by IFN-α, IFN-γ, IL-4, IL-13, IL-4/IL-13 45 ; Wnt and Notch please see Supplementary Table 4 . Simpson's index of diversity, and fibroblast gene correlation with basal cell frequency. To measure the 'richness' of the epithelial ecosystem 46 , we employed Simpson's index of diversity (D), which we present as (1−D), and ranges between 0 and 1, with larger values indicating larger sample diversity 47 . We used Simpson's index to characterize the composition of epithelial cells across basal, differentiating/secretory, glandular, and ciliated groupings in the non-polyp and polyp ethmoid sinus tissue ecosystems, as this metric accounts for both the number of distinct cell types present (for example, species), and the evenness of the cellular composition across those cell types (for example, relative abundance of species to each other). This measure takes into account the total number of members of a cell type, the number of cell types, and the total number of cells present. We calculate (1−D) for each sample. To determine genes correlated in specific cell types (for example, fibroblasts) with the frequency of basal cells present in a cellular ecosystem, we correlated the average log-normalized single-cell count data for each gene to the rank of samples determined by increasing frequency of basal cells in each ecosystem (8.2% to 19.1% for non-polyp and 27.9% to 70.1% for polyp samples, Extended Data Fig. 7b ). Tissue and sorted basal cell RNA-seq. Population RNA-seq was performed using a derivative of the Smart-Seq2 protocol for single cells 48 . In brief, tissue was collected directly into RNAlater (Qiagen) in the surgical suite and stored at −80 °C until RNA isolation. RNA was isolated from 30 patients using phenol/chloroform extraction and normalized to 5 ng as the input amount for a 2.2X SPRI ratio cleanup using Agencourt RNAClean XP beads (Beckman Coulter, A63987). RNA-seq was performed on a bulk population of sorted basal cells using Smart-Seq2 chemistry, starting with a 2.2X SPRI ratio cleanup. After oligo-dT priming, Maxima H Minus Reverse Transcriptase (ThermoFisher EP0753) was used to synthesize cDNA with an elongation step at 52 °C before PCR amplification (15 cycles for tissue, 18 cycles for sorted basal cells) using KAPA HiFi PCR Mastermix (Kapa Biosystems KK2602). Sequencing libraries were prepared using the Nextera XT DNA tagmentation kit (Illumina FC-131-1096) with 250 pg input for each sample. Libraries were pooled post-Nextera and cleaned using Agencourt AMPure SPRI beads with successive 0.7X and 0.8X ratio SPRIs and sequenced with an Illumina 75 Cycle NextSeq500/550v2 kit (Illumina FC-404-2005) with loading density at 2.2 pM, with paired end 35 cycle read structure. Tissue samples were sequenced at an average read depth of 7.98 million reads per sample and 3 samples not meeting quality thresholds were excluded from further analyses yielding 27 total useable samples. Sorted basal cell samples were sequenced at an average read depth of 21.15 million reads per sample and all samples met quality thresholds regarding genomic and transcriptomic alignment. Tissue and sorted basal cell RNA-seq data analysis. Tissue and sorted basal cell samples were aligned to the Hg19 genome and transcriptome using STAR 49 and RSEM 50 . Three samples were excluded for low transcriptome alignment (<25%), so we retained 27 samples for further analyses. Differential expression analysis was conducted using DESeq2 package for R 51 . Genes regarded as significantly differentially expressed were determined based on an adjusted P value using the Benjamini-Hochberg procedure to correct for multiple comparisons with a false discovery rate <0.05. We performed ingenuity pathway analysis (IPA, Qiagen) through an instance available through the Broad Institute on the top 1,000 differentially expressed genes (all adjusted P < 0.05) from our DESeq2 analysis, taking into account corresponding log-fold change for each gene. We also subset the tissue RNA-seq matrix based on genes found in Supplementary Table 3 , which, from our single-cell marker discovery, were specific for basal, differentiating/secretory, glandular, or ciliated cells. We then ran PCA and kNN clustering implemented in R over these genes in order to identify the greatest vectors of variance across samples within the epithelial cell compartment (Fig. 3f, g) .
For re-analysis of published data, we used two publicly-available RNA-seq datasets: one profiling normal human olfactory mucosa and the other assessing differences in gene expression between healthy, non-eosinophilic nasal polyps and eosinophilic nasal polyps 7, 52, 53 . Note that analysis is done on a per sample basis and as such no comparisons are made across the datasets or samples. Diffusion pseudotime mapping for differentiation analysis. Using diffusion pseudotime 54 mapping, which seeks to provide the most likely reconstruction for the developmental progression of a set of cells we built a trajectory for cells within basal and differentiating/secretory epithelial clusters (non-polyp clusters: 8-basal, 1-differentiating/secretory, 4-secretory; and polyp clusters: 12-basal, 2-basal, 0-differentiating/secretory; running several iterations starting from a random seed cell in cluster 8), over the combined basal and apical marker gene list ( Fig. 4d ; Extended Data Fig. 9a, Supplementary Table 3 ). By calculating a pseudotime trajectory for cells from both non-polyps and polyps together, we were then able to ask where cells from each disease state fall along a shared inferred temporal axis ( Fig. 4d, e ; Extended Data Fig. 9a ). Diffusion pseudotime 54 was calculated using the scanpy Python package 'dpt' function on log-normalized data for clusters 8, 1 and 4 (predominantly non-polyp, Supplementary Table 3 ) and 12, 2, and 0 (predominantly polyp, Supplementary Table 3 ) together. A random root cell was chosen from cluster 8, as this was the basal cell cluster representative of the non-polyp (for example, less aberrant) state, and we also ran iterations with random root cells chosen from the entire set of clusters and it assigned cluster 8 as the cluster most enriched at the beginning of the diffusion map, regardless. Plots were created with the seaborn, matplotlib and pandas packages. Pearson correlations were then calculated for all genes in all cells tested, or for all genes in non-polyp cells and all genes in polyp cells, relative to pseudotime (Extended Data Fig. 9b ). Differential correlation testing was performed using the cocor package to identify significance for the difference between correlation coefficients using Fisher's 1925 z-statistic, accounting for number of cells. Epigenetic profiling of basal cells using Omni-ATAC-seq. Accessible chromatin profiling 55 using the Omni-ATAC-seq protocol as described in Corces et al. 56 was performed on basal cells stored in 100 μl BAMBanker freezing media from 12 patients (n = 4 non-polyp (3 retained after data quality filtering) and n = 8 polyp). Cells (ranging from 1,000 to 10,000) were thawed quickly in a 37 °C rock bath and 900 μl of ice-cold PBS supplemented with Roche Complete Mini Protease inhibitor was added immediately. Cells were split into two 1.5-ml Eppendorf DNA lo-bind tubes to serve as technical replicates. Cells were centrifuged at 500g for 5 min at 4 °C, washed once in PBS with protease inhibitor, centrifuged at 500g for 5 min at 4 °C and supernatant was removed completely using two separate pipetting steps with extreme caution taken to avoid resuspension (for example, smooth and consistent aspiration). The transposition reaction consisted of 20-μL total volume of the following mixture (10 μl 2× TD Buffer, 1 or 0.5 μl TDEnzyme, 0.1 μl of 2% digitonin, 0.2 μl of 10% Tween 20, 0.2 μl of 10% NP40, 6.6 μl of 1× PBS and 2.3 μl of nuclease-free water). We performed replicates with two distinct concentrations of TDE since, when dealing with minute clinical samples, flow sorting can sometimes give variable cell numbers, and the ratio of TDE to cells is critical in determining the frequency with which cuts are made in the genome. We optimized in pilot experiments that for basal cell inputs in the range of 500 to 10,000 cells, the aforementioned two ratios gave expected patterns of nucleosome banding in gels (data not shown). We performed two reactions and then later, during in silico analysis, pooled peaks together for downstream analysis. The cells were resuspended into the transposition mixture and incubated at 37 °C for 30 min in an Eppendorf Thermomixer with agitation at 300 r.p.m. Transposed DNA was purified using a Qiagen MinElute Reaction Cleanup Kit with elution in 15 μl. Libraries were constructed from 10 μl of DNA using a 50 μl total reaction volume of NEB HF 2X PCR Master Mix with custom Nextera N700 and N500 index primers to barcode samples (also used in Smart-Seq2 protocol). We performed 14 cycles of PCR amplification and SPRI purified at 1.8× ratio. Based on the molarity of each library, we adjusted the number of subsequent PCR cycles to either 3, 4 or 5 more for each sample. We then performed a 0.25× reverse SPRI to remove larger fragments followed by a 1.7× SPRI to purify libraries for sequencing. Libraries were sequenced on an Illumina NextSeq with paired-end 38-cycle read structure at a loading density of 1.95 pM. Omni-ATAC-seq data analysis. Reads were aligned using bowtie2 using the following flags: '-S -p 1 -X 2000 --chunkmbs 1000' then bams were created using samtools view with the following flags: 'samtools view -bS -F 4' . Duplicates were removed with picard. Forward reads were shifted 4 bp and negative reads were shifted 5 bp using a custom Python script and the pysam package as is recommended for ATAC-seq data. Samples for each patient were merged using samtools merge and all patients were downsampled to 3 million reads using custom python scripts and 'samtools view' with the '-b' and '-s' flags. MACS2 'callpeak' command was used to call peaks on each sample with flags '-f BAMPE -q 0.001 --nomodel --shift -100 --extsize 200 -B --broad' . Peaks from all samples were merged into one peakfile with bedtools and counts of reads per peak for each sample was generated with bedtools multicov. DESeq2 was run with the design ~polyp, testing for significant differences between polyp and non-polyp samples on this peak matrix and differential peaks with Benjamini-Hochberg adjusted P value less than 0.01 with 'greater' or 'less' null hypotheses were used in downstream analysis. Homer2 was run for known motif finding on differential peaks with the set of all peaks as background 57 . To determine a false discovery rate, Homer2 was run on sets of random peaks chosen with replacement from the set of all peaks. Epithelial cell culture. Tissues were digested as described above from either nonpolyp or polyp surgical resections from the ethmoid sinus. 1,000,000 digested cells were added to a 25-cm 2 tissue culture flask (Corning) pre-coated with 0.03 mg/ml Type I bovine collagen solution (StemCell Technologies) and cultured in PneumaCult-Ex media (StemCell Technologies, 05008). Media was changed every second day until cells reached confluence. Cells were subsequently frozen in 70% basal media with 20% FBS and 10% DMSO. Air-liquid interface cultures. For air-liquid interface (ALI) cultures 58 , 100,000 cultured epithelial cells per well were added to 0.4-μm pore 24-well polyester membrane inserts (Corning) pre-coated with 0.03 mg/ml Type I bovine collagen solution (StemCell Technologies) with Pneumacult-Ex media (StemCell Technologies, 05008) on both sides of the membrane. After 24 h, apical media was changed to remove dead cells. After 72 h, apical media was removed completely and basal media was changed to Pneumacult-ALI (StemCell Technologies, 05001) supplemented with 5 ml 100× penicillin-streptomycin (Fisher), 1 ml 500× gentamicin/amphotericin B (ThermoFisher), 1 ml 0.2% heparin sodium salt in PBS (StemCell Technologies) and 2.5 ml 200× hydrocortisone stock solution (StemCell Technologies) and 0, 0.1, 1 or 10 ng/ml IL-13 (Biolegend). Basal media was changed every 2-3 days for 21 days, after which membranes were removed and cells dissociated with Stempro Accutase Cell Dissociation Reagent (Gibco) for Seq-Well or flow cytometry. After following scRNA-seq data analysis pipelines described above, cell states recovered in ALI cultures ( Fig. 5a; Extended Data Fig. 9g ) were related to in vivo cell types 59 . Basal cell stimulation. Basal cells from non-polyp or polyp surgical resections from ethmoid sinus were placed into epithelial cell culture (for example, 'lateral expansion' in the absence of differentiation, see above, inspired by experiments in microglia 60 ), passaged, and 10,000 cells seeded at passage 5 (for example, 5 weeks ex vivo) and cultured at confluence in 96-well flat-bottom collagen-coated tissue culture plates (Corning, 3799) for 48 h in Pneumacult-Ex serum-free media (StemCell Technologies, 05008). Cytokines were added for 12 h overnight at increasing doses (0, 0.1, 1, 10 ng/ml) of IL-4 (Biolegend 766205), IL-13 (Biolegend 571104), and Letter reSeArCH (0.1, ng/ml) IL-4 + IL-13 in combination (n = 32 samples non-polyp and n = 32 samples polyp basal cells over all conditions, each condition run as a biological duplicate, and a technical duplicate therein), before lysis using RLT + 1% BME (Qiagen and Sigma, respectively). Bulk RNA-seq was performed as described for sorted basal cells starting from lysates. Basal cell stimulation samples were sequenced at an average read depth of 3 million reads per sample and all samples met quality thresholds regarding genomic and transcriptomic alignment. Statistical analyses. No statistical methods were used to predetermine sample size. Number of samples included in analyses are listed throughout figure legends and all represent distinct biological samples. The same surgeon performed surgeries on all individuals and was blinded to study design. The same allergist/immunologist performed nasal scrapings on all samples and was blinded to study design. Quantification of histological sections was performed in a blinded fashion. No samples or cells meeting quality thresholds were excluded from analyses. Where single-cell data was analysed on a gene level, the statistics were performed over the number of cells. Statistical analyses were performed using GraphPad Prism v7.0a, Seurat 1.4.0.1 implemented in RStudio, DESeq2 1.10.1 package implemented in RStudio, and Ingenuity Pathway Analysis run through the Broad Institute, and macs2, DESeq2 and Homer2 for Omni-ATAC-seq. All violin plots were generated using standard Seurat code without modification to smoothing or density. Violin density only generated when >25% of cells in indicated sample have non-zero measurement for gene, widest aspect represents centre of positive measures, minima and maxima are represented within the scale with minima at 0 and maxima encompassing all points for the count-based expression level (log(scaled UMI + 1)) of each gene. Exact values for all genes displayed and tested available in Supplementary Table 3 organized by panel. All violin plots contain at minimum 100 individual cells in any one cluster (Supplementary Table 3 for precise numbers of cells per cluster and type, most are included in figure legends where space allows), and have points suppressed for ease of legibility. Some violin plots with less than 100 cells have individual data points displayed and corresponding statistical metrics are available in accompanying figure legend and Supplementary Table 3 . As some scores followed non-normal distributions as tested for using a Lilliefors normality test, we used a Mann-Whitney U-test where indicated for determining statistical significance. For scores in single-cell data, we report effect sizes in addition to statistical significance as an additional metric for the magnitude of the effect observed. The calculation was performed as Cohen's d where: effect size d = (Mean 1 -Mean 2 )/(s.d. pooled). Unpaired two-tailed t-tests for direct comparisons and t-test with Holm-Sidak correction, Bonferroni correction, or Benjamini-Hochberg for multiple comparisons, depending on software package used, where appropriate. Mann-Whitney U-test for quantification of histological data due to non-normally distributed data. Pearson correlation thresholds were determined as significant through determination of asymptotic P values through use of rcorr function in Hmisc, but exact corrected P values by Holm-Sidak method for multiple comparisons are calculated for those highlighted in text using RcmdrMisc package. Comparison of Pearson correlation coefficients in pseudotime analyses was done using Fisher's 1925 z-statistic accounting for the number of cells. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data availability. The cells-by-genes matrix generated from EthSin surgical resections and analysed during the current study is available along with the manuscript as Supplementary Table 2 alongside R code for standard implementation of Seurat. A cells-by-genes matrix from InfTurb and polyp scraping data are also available as Supplementary Table 6 . Dupilumab treatment cells-by-genes matrices are shown in Supplementary Tables 7 and 8. A metadata table encompassing all scRNA-seq  samples is provided as Supplementary Table 9 . The count and TPM matrices and associated metadata from bulk tissue RNA-seq are available as Supplementary Tables 10, 11, and 12. FASTQ file format data have been deposited in and are available from the dbGaP database under dbGaP accession 30434 (https://www.ncbi. nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs030434.v1.p1). Marker gene lists for cell types identified in Fig. 1a, b and from resultant analyses in Fig.  2b , for frequencies of cell clusters and types in Fig. 2c , for cell types identified in Fig. 2e, f, 3g , 5a, e, Extended Data Fig. 3a-c, 4c, 5e, 6b, d, 10a , selected comparisons of differential expression in Figs. 2d, 4a , 5c, f, Extended Data Fig. 2c , 10h, and pseudotime correlation in Extended Data Fig. 9b are available as tabs in Supplementary Table 3 . Differential peak calling from epigenetic profiling is available in Supplementary Table 5 . Additional R code for analyses is available at http://shaleklab.com/resources/. Aligned and quality-filtered data and complete statistical outputs for the figures are included as Supplementary Tables, with further information at http://shaleklab.com/resources/ . Fig. 9 | Pseudotime analysis on basal and differentiating/ secretory cell clusters from EthSin, transcriptional motif enrichments in non-polyp and polyp basal cells, and the identity of cell types in air-liquid interface cultures. a, Pseudotime analysis using diffusion mapping (see Methods) of selected clusters of epithelial cells, here displaying diffusion pseudotime (related to Fig. 4d ). Clusters 8/1/4, 3,516 cells; clusters 12/2/0, 4,064 cells. n = 6 non-polyp, n = 6 polyp samples. Diffusion map and diffusion coefficients (DC) are calculated over the set of basal and apical marker genes identified in Fig. 1a (see Supplementary  Table 3 ). b, The top 60 negatively correlated genes expressed in non-polyp cells with pseudotime trajectory and Pearson correlation values for genes in polyp cells also displayed; differential correlation coefficient analysis using Fisher's z-statistic, accounting for number of cells in each group (specific genes highlighted, all >2z; full results including Bonferroni corrected P values in Supplementary Table 3 ). c, Correlation matrices (row and column clustered) of the normalized read counts per sample in motifassociated peaks for non-polyp or polyp samples. Pearson correlation, n = 3 non-polyp, n = 7 polyp. d, A column-normalized heat map (row and column clustered) for the fraction of peaks with a motif corresponding to accessibility of the respective transcription factor displayed by patient. n = 3 non-polyp, n = 7 polyp. e, IGV tracks for ATF3 and KLF5 based on peaks detected and averaged by non-polyp and polyp samples from ATACseq profiling. f, IGV tracks for S100A9 and MUC4 based on peaks detected and averaged by non-polyp and polyp samples from ATAC-seq profiling. g, Violin plots for the count-based expression level (log(scaled UMI + 1)) for key marker genes using ROC test across cell types identified in Fig. 5a , Supplementary Table 3 . 1,345 basal; 6,420 secretory; 6,381 hybrid; and 2,027 ciliated cells from n = 2 non-polyp and n = 2 polyp patients. AUC = 0.943 (KRT5), 0.667 (TP63), 0.644 (LYPD2), <0.55 (SPDEF), <0.55 (KRT8), 0.602 (BPIFA1), 0.813 (PIFO), 0.73 (FOXJ1). h, Row-normalized heat map for ALI secretory cells (subsampled to 300 cells per donor) as in Fig. 2f of the top in vivo secretory marker genes identified by ROC test (AUC > 0.662) with select genes displayed on y axis including a core secretory signature (ROC test, secretory cells versus rest of cells), and then within secretory cells, ROC test was used to identify marker genes within each disease/location category; and basal-cell derived annotations on x axis (see Supplementary Table 3 for full gene lists, all AUC > 0.65 for markers displayed in Fig. 2f ). i, Quantification of flow cytometry for the ratio of basal to Epcam hi cells (gating as in Extended Data Fig. 7h ) from ALI cultures at 21 days, stimulated with the indicated doses of IL-13. Points represent individual biological replicates; n = 6 non-polyp, n = 5 polyp samples for each dose. Two-way ANOVA; not significant between disease groups at any dose tested; Two-way ANOVA, P = 0.0224 for IL-13 dose. Data are mean ± s.e.m. j, Expression levels for CTGF (log 2 expression value of log-normalized count data) in basal cells from non-polyp or polyp individuals across doses of cytokines displayed. n = 4 samples each dose. Two-way ANOVA P < 0.0260 for CTGF; all conditions non-polyp versus polyp except 0.1 ng ml −1 IL-4 dose for CTGF. Fig. 10 | In vivo blockade with an anti-IL-4Rα monoclonal antibody shifts secretory cell state towards healthyassociated genes. a, Left, t-SNE plot of 8,764 single cells (related to Fig. 5e ) from the nasal polyps of an individual treated with dupilumab (IL-4Rα monoclonal antibody) (1 patient, sampled at n = 3 time points), coloured by clusters identified through SNN analysis (Supplementary Table 3 ; Methods); middle, t-SNE plot coloured by time point and tissue of origin from polyp pre-dupilumab scraping (5,731 cells), from polyp post-dupilumab scraping (647 cells), and polyp post-dupilumab surgical sample (2,386 cells); right, t-SNE plot coloured by cell types identified through marker discovery (ROC test) and biological curation of identified clusters ( Supplementary Table 3 ; Methods). b, Select cell-type specific score overlays for cell types indicated in original core dataset (see Supplementary Table 3 for full gene list). c, Row-normalized heat map for myeloid cells of the top marker genes identified by ROC test (AUC > 0.8) with select genes displayed on y axis including a core myeloid signature (ROC test myeloid cells versus rest of cells), and then genes found to be differentially expressed from Fig. 5f in basal cells, and treatment annotations on x axis. Bimodal test. *, differential genes in both basal cells and myeloid cells pre-versus post-treatment (P < 0.003 or less with Bonferroni correction for multiple hypothesis testing based on number of genes tested). d, Violin plots for basal cells (200 cells pre-dupilumab and 151 cells post-dupilumab, noted in a) for the count-based expression level (log(scaled UMI + 1)), except where indicated for gene scores, fraction of transcriptome and z-score (see Methods, Supplementary Table 4 for gene set used) for key basal cell genes for selected biological processes, or from the baseline upregulated gene set from polyp basal cells in vitro (Fig. 5c ). Differential expression testing for decreased expression post-treatment using bimodal test not significant except where indicated (*P < 0.00087 or less with Bonferroni correction for multiple hypothesis testing based on number of genes tested; see Supplementary Table 3 for full list). Basal in vitro score pre versus post: two-tailed t-test, P < 3.897 × 10 −15 , effect size 0.822. e, t-SNE plot of 4,486 single cells (related to Figs. 2e, 5e ) from the inferior turbinate or nasal polyps of an anti-IL-4Rα (dupilumab) treated individual (n = 4 samples) coloured by time point and tissue of origin (left) from inferior turbinate pre-dupilumab scraping (643
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A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code Data collection STAR, RSEM, R, Seurat 1.4.0.1 (and associated functions therein as described in Methods), GraphPad Prism, DESeq2 1.10.1, Ingenuity Pathway Analysis, HOMER, macs2, FlowJo, scanpy, seaborn, matplotlib, pandas, bowtie2, samtools, ImageJ Data analysis STAR, RSEM, R, Seurat 1.4.0.1 (and associated functions therein as described in Methods), GraphPad Prism, DESeq2 1.10.1, Ingenuity Pathway Analysis, HOMER, macs2, FlowJo, scanpy, seaborn, matplotlib, pandas, bowtie2, samtools, ImageJ. Example walk-through script included as R Script in Supplementary Information for generating Analysis from core data set in Figure 1 . Additional walk-through scripts available on http://shaleklab.com/resources. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. 
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Population characteristics
Supplementary Table 1 provides the full clinical characteristics of single-cell patients and tissue RNAseq patients, histology, flow cytometry, and ATAC-seq/RNA-seq patients describing the gender, age, diagnosis, nasal polyp grade, h/o atopy, asthma and/or sinus infection, number of previous surgeries, ASA tolerance, oral steroid use, topical steroid use, immunosuppressant use, leukotriene modification, and antibiotic use. We refer the interested reader to Supplementary Table 1 for this information given the difficulty in displaying it within the space provided here.
Recruitment
Subjects between the ages of 18 and 75 years were recruited from the Brigham and Women's Hospital (Boston, Massachusetts) Allergy and Immunology clinic and Otolaryngology clinic between May 2014 and March 2018 (Supplementary Table 1 ). The Institutional Review Board approved the study, and all subjects provided written informed consent. There was a low chance for recruitment bias as individuals were receiving necessary surgical care for their respective diagnosis.
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Methodology Sample preparation
Single-cell suspensions in FACS Buffer (HBSS -/-supplemented with 2% FCS) were pre-incubated with Fc-Block before staining for surface antigens. Cells were stained for 30 minutes on ice in FACS buffer and then washed for immediate sorting.
Instrument BD FACSAria Fusion
Software BD FACSDiva Software for collection and FlowJo v10 by TreeStar for analysis Cell population abundance Purity of samples was determined from parallel samples sorted for functional assays as sorting into lysis buffer for ATAC-seq and RNA-seq precludes re-sorting to check purity.
